Replies to post #128392 on Biotech Values

[Regulardoc]

I'm guessing that the primary thrust would be to ask the court if they can bid out their product in case the court lifts the TRO in the future. Amphastar earlier mentioned issues with GPO deadlines.

Would not be unreasonable to grant the allowance for bids as long as no product shipped.